{"meta":{"query_hash":"4d53a0d75cf7","filters":{"venue":"Drug Resistance Updates"},"cohort_total":36,"direct_labels_cover":0,"predictions_cover":36,"exported":36,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4d53a0d75cf7","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drug+Resistance+Updates"},"results":[{"id":"W1964137986","doi":"10.1016/s1368-7646(02)00003-1","title":"Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway","year":2002,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":150,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Cancer Institute","keywords":"XIAP; Ovarian cancer; PI3K/AKT/mTOR pathway; Protein kinase B; Cancer research; Cisplatin; Inhibitor of apoptosis; Programmed cell death; Apoptosis; Biology; Kinase; Cancer; Signal transduction; Cancer cell; Cell biology; Caspase; Chemotherapy; Genetics","score_opus":0.009680834590482428,"score_gpt":0.23520781452432837,"score_spread":0.22552697993384593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964137986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004321666,0.99721104,0.00035199153,0.00036054914,0.00044176372,0.0000047256826,0.00001687251,0.000013682631,0.0011671502],"genre_scores_gemma":[0.0019035494,0.99475265,0.00061004143,0.000379216,0.00039452707,0.000008691734,0.00005181509,0.0000022852319,0.0018972767],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998907,0.000013924155,0.000016966773,0.000023672192,0.00004300098,0.000011786393],"domain_scores_gemma":[0.999795,0.00008085875,0.000027001039,0.000006092137,0.00006904583,0.000021943903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056352816,0.00081215415,0.0012803907,0.0009613676,0.00025475808,0.00089602196,0.0008133205,0.0010888615,0.0017719361],"category_scores_gemma":[0.00035578475,0.00017880893,0.00032813003,0.0011590061,0.00039699336,0.0009948981,0.00033193338,0.0014760231,0.0019007364],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024410764,0.00010218671,0.0004896241,0.0051118946,0.00008477904,0.0007862963,0.00004158075,0.00032898813,0.0074265776,0.002284898,0.032788012,0.9503111],"study_design_scores_gemma":[0.00009999884,0.0003106824,0.0025383835,0.0009746766,0.00021439038,0.0048665344,0.00007408364,0.00023846352,0.0038200417,0.0016605227,0.98517275,0.0000294479],"about_ca_topic_score_codex":0.00070703495,"about_ca_topic_score_gemma":0.0013716872,"teacher_disagreement_score":0.0017719361,"about_ca_system_score_codex":0.000520208,"about_ca_system_score_gemma":0.0006612203,"threshold_uncertainty_score":0.005927682},"labels":[],"label_agreement":null},{"id":"W1965156600","doi":"10.1016/j.drup.2011.04.002","title":"The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms","year":2011,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Government of Ontario","keywords":"Efflux; Kinase; Biology; Cancer research; Pharmacology; Signal transduction; Cancer; Drug resistance; Cell biology; Genetics","score_opus":0.03263143506265965,"score_gpt":0.2976015274292069,"score_spread":0.2649700923665473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965156600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023923391,0.9964998,0.00030423724,0.00056700164,0.00027705898,0.00000595567,0.000023932987,0.000016036649,0.0020668283],"genre_scores_gemma":[0.0010830025,0.99671704,0.0003735007,0.00031394346,0.00027246316,0.000006962224,0.000043696335,0.000001670822,0.0011877347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985063,0.000019863333,0.000016945105,0.00002300669,0.00007341221,0.000016151333],"domain_scores_gemma":[0.99982065,0.000072778595,0.000030874555,0.000006010553,0.000050167804,0.000019586952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004945599,0.0008715562,0.0012565635,0.0012317989,0.00020542621,0.0009788241,0.00065152586,0.0007506215,0.0024260588],"category_scores_gemma":[0.00044826284,0.00022728203,0.00034294734,0.0012869094,0.0004067204,0.0010517646,0.0006133415,0.0020977757,0.001654128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008616117,0.000052780237,0.00015106608,0.005006984,0.000056786088,0.00016494667,0.000022204267,0.0002783389,0.0040789107,0.002544249,0.028978987,0.9585785],"study_design_scores_gemma":[0.00004016275,0.000079784775,0.0008539599,0.0011492163,0.00012762501,0.001146754,0.000034131837,0.00019169165,0.0016464567,0.0018244794,0.9928866,0.000019109122],"about_ca_topic_score_codex":0.0005469892,"about_ca_topic_score_gemma":0.001446518,"teacher_disagreement_score":0.0024260588,"about_ca_system_score_codex":0.00061891513,"about_ca_system_score_gemma":0.00070749497,"threshold_uncertainty_score":0.008115947},"labels":[],"label_agreement":null},{"id":"W1969152525","doi":"10.1016/j.drup.2004.06.001","title":"The emergence of HIV resistance and new antiretrovirals: are we winning?","year":2004,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Human immunodeficiency virus (HIV); Resistance (ecology); Perspective (graphical); Antiretroviral therapy; Virology; Medicine; Biology; Viral load; Computer science; Artificial intelligence; Ecology","score_opus":0.032059933540730744,"score_gpt":0.3110628451451023,"score_spread":0.2790029116043716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969152525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051413805,0.9920466,0.000097373464,0.004447789,0.0025090135,0.0000024528786,0.000007721538,0.0000106620755,0.00082699273],"genre_scores_gemma":[0.00047194774,0.9910964,0.00027326183,0.0033429996,0.0034726807,0.000005738002,0.000019397014,0.0000025278543,0.0013150888],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99929893,0.00019112161,0.00007462998,0.000074374264,0.00028411933,0.00007686451],"domain_scores_gemma":[0.9977863,0.0010792428,0.00017686392,0.000053520627,0.0006356702,0.000268419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002476108,0.0013077453,0.0031246836,0.0015405348,0.0006778167,0.0028884108,0.0014839739,0.0050039347,0.006108579],"category_scores_gemma":[0.0035379482,0.00041626944,0.00060460187,0.0021642456,0.0014482064,0.0055718985,0.00090120675,0.0055501116,0.0037961467],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014553733,0.00006530606,0.00026578899,0.0044524106,0.000055542954,0.00026918194,0.00007545691,0.0001489807,0.00041925305,0.0034205355,0.23523922,0.7554427],"study_design_scores_gemma":[0.000030208743,0.00006138071,0.00045395488,0.0016241069,0.000053485765,0.00088603987,0.00011288468,0.00004433678,0.000058553913,0.0017500278,0.99491274,0.00001222384],"about_ca_topic_score_codex":0.0024531996,"about_ca_topic_score_gemma":0.0066212835,"teacher_disagreement_score":0.006108579,"about_ca_system_score_codex":0.0014046096,"about_ca_system_score_gemma":0.0028597098,"threshold_uncertainty_score":0.020435214},"labels":[],"label_agreement":null},{"id":"W1971110677","doi":"10.1016/j.drup.2004.02.004","title":"New cancer therapeutics: target-specific in, cytotoxics out?","year":2004,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pyrogenesis (Canada)","funders":"","keywords":"Cancer; Clinical trial; Biomarker; Medicine; Drug development; Proteomics; Targeted therapy; Biomarker discovery; Computational biology; Drug; Cancer research; Bioinformatics; Pharmacology; Biology; Internal medicine","score_opus":0.008700666978959477,"score_gpt":0.24758091442834745,"score_spread":0.238880247449388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971110677","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01870415,0.7020344,0.016059116,0.21406066,0.015983775,0.000104833794,0.00029243898,0.0007719156,0.0319887],"genre_scores_gemma":[0.117206246,0.6685441,0.02036533,0.12607257,0.02876177,0.00014722416,0.00043128626,0.00033561134,0.038135953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992174,0.00018219558,0.00011473356,0.00011044674,0.00027147582,0.00010374887],"domain_scores_gemma":[0.99781275,0.00094389176,0.00017914113,0.00016419048,0.0007002331,0.00019974615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004132567,0.00070366095,0.0018737715,0.0007174922,0.0007862572,0.0029674596,0.0011292192,0.0027526033,0.009456234],"category_scores_gemma":[0.0034986658,0.00046279965,0.00068450655,0.00059734733,0.0015936967,0.0075104176,0.0010032046,0.0061749844,0.0024355252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005550699,0.00028523544,0.0010936277,0.0024144156,0.00014171496,0.00048810852,0.00033497336,0.00065082934,0.017649038,0.03249652,0.14084454,0.8030458],"study_design_scores_gemma":[0.00018212757,0.0007953704,0.0012329203,0.0005329732,0.00022554466,0.0019917386,0.00047813996,0.0009225595,0.0072682984,0.026363917,0.95993996,0.00006655101],"about_ca_topic_score_codex":0.0005955078,"about_ca_topic_score_gemma":0.0026408378,"teacher_disagreement_score":0.009456234,"about_ca_system_score_codex":0.0011816769,"about_ca_system_score_gemma":0.0011110757,"threshold_uncertainty_score":0.03163427},"labels":[],"label_agreement":null},{"id":"W1973344697","doi":"10.1016/j.drup.2015.01.001","title":"RhoGTPases – A novel link between cytoskeleton organization and cisplatin resistance","year":2015,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"RhoC; RHOA; RHOB; Biology; Actin cytoskeleton; Cell biology; PAK1; CDC42; Cisplatin; GTPase; Cytoskeleton; Cancer research; Kinase; Signal transduction; Cell; Genetics","score_opus":0.022949022113287282,"score_gpt":0.2889868471376309,"score_spread":0.2660378250243436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973344697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019111774,0.99798054,0.00020735507,0.000667714,0.00031848962,0.000003048861,0.000021137408,0.000010151856,0.00060046714],"genre_scores_gemma":[0.0011777289,0.9970542,0.0002309451,0.00033346063,0.0004454375,0.000004351005,0.00004518049,0.0000016147923,0.0007070485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998864,0.000014044283,0.000018505843,0.000022706987,0.000044809076,0.000013559633],"domain_scores_gemma":[0.999848,0.000058724178,0.000026766413,0.0000055148867,0.00004234365,0.000018650342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041117298,0.0005860282,0.0009940459,0.0010223307,0.00018897376,0.0009129268,0.0006235386,0.0010512063,0.0020927666],"category_scores_gemma":[0.0005261412,0.00020970387,0.00030190425,0.0009844674,0.00043308147,0.0011371684,0.0006409599,0.0017965698,0.001232213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012771058,0.00004803367,0.00026400588,0.007920248,0.000080296566,0.00031813135,0.000044238248,0.00031974126,0.004262044,0.0057254583,0.04613652,0.9347536],"study_design_scores_gemma":[0.00002429846,0.00006700726,0.0009873864,0.0012946136,0.00012935231,0.0013303277,0.000043346485,0.00016203291,0.0009043239,0.0026570559,0.9923805,0.000019885156],"about_ca_topic_score_codex":0.0005417115,"about_ca_topic_score_gemma":0.0014664017,"teacher_disagreement_score":0.0020927666,"about_ca_system_score_codex":0.0004738751,"about_ca_system_score_gemma":0.0008055112,"threshold_uncertainty_score":0.0070010424},"labels":[],"label_agreement":null},{"id":"W1976097884","doi":"10.1054/drup.2001.0190","title":"Lamivudine resistance in hepatitis B: mechanisms and clinical implications","year":2001,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lamivudine; Virology; Hepatitis B virus; Hepatitis B; Medicine; Nucleoside analogue; Seroconversion; Orthohepadnavirus; Immunology; Viral replication; Biology; Virus; Hepadnaviridae; Nucleoside; Genetics","score_opus":0.04996537674272774,"score_gpt":0.37843679687202997,"score_spread":0.32847142012930225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976097884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077739634,0.9993332,0.000035629866,0.00020208598,0.00009051291,0.0000021842889,0.000008061936,0.0000026421858,0.00024787092],"genre_scores_gemma":[0.0003459073,0.9991198,0.00011728645,0.00016379161,0.00010612979,0.0000027846697,0.000010026565,3.8179982e-7,0.0001339903],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968505,0.00008502999,0.0000661349,0.000046979167,0.00009768522,0.000019148003],"domain_scores_gemma":[0.9987923,0.0007176108,0.00017582992,0.00002277934,0.0002402006,0.000051269897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016141206,0.000830498,0.0021674011,0.0026105249,0.00025262157,0.0012151801,0.00089099124,0.0012488021,0.002721565],"category_scores_gemma":[0.001992083,0.00025440127,0.00055156974,0.0042082123,0.0004896286,0.0015050498,0.00048180652,0.0011171855,0.0009867699],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014775124,0.00004638159,0.0004072515,0.020817557,0.00013417413,0.00022154339,0.000051866504,0.00013990434,0.0007282954,0.00085014757,0.021010831,0.9554444],"study_design_scores_gemma":[0.00012121366,0.00024258262,0.003434939,0.010581799,0.00078439264,0.0024011275,0.00020200592,0.000102437436,0.00044773266,0.0013400384,0.9803105,0.000031115283],"about_ca_topic_score_codex":0.0019626336,"about_ca_topic_score_gemma":0.004899518,"teacher_disagreement_score":0.002721565,"about_ca_system_score_codex":0.0007438021,"about_ca_system_score_gemma":0.0017557213,"threshold_uncertainty_score":0.0091046095},"labels":[],"label_agreement":null},{"id":"W1986171300","doi":"10.1016/j.drup.2004.06.004","title":"Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling","year":2004,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Institute for Research in Immunology and Cancer; McGill University","funders":"National Cancer Institute; Cancer Research Society; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance; Cancer Research Institute","keywords":"Drug resistance; Proteomics; Computational biology; Drug; Biology; Bioinformatics; Drug response; Cancer; Tumor microenvironment; Drug development; Medicine; Pharmacology; Gene; Genetics","score_opus":0.01158990424308681,"score_gpt":0.2557509097724516,"score_spread":0.24416100552936476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986171300","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009095732,0.9910631,0.0049057193,0.0010187912,0.0003780472,0.000013443081,0.00011177634,0.000074715805,0.0015247004],"genre_scores_gemma":[0.0040616575,0.98720133,0.005508117,0.0006776078,0.0005320264,0.00002282007,0.00022579594,0.000009060463,0.0017615143],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995846,0.000056765897,0.00003768622,0.00010708687,0.0001900193,0.000023873901],"domain_scores_gemma":[0.9989631,0.0005361757,0.0000886228,0.000040348048,0.00031801214,0.000053751217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018584667,0.0013436339,0.002586772,0.0015757866,0.00019752128,0.0014778185,0.0013541211,0.0015310694,0.0010762438],"category_scores_gemma":[0.0015856134,0.00038285865,0.0005657573,0.0019625253,0.00063534593,0.0015158008,0.00046298694,0.0019656678,0.0016916784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015121288,0.00008499627,0.0010563914,0.0025985106,0.00009792971,0.00014008932,0.00002433301,0.0006766423,0.0071878126,0.0016735905,0.015775057,0.9705335],"study_design_scores_gemma":[0.00010464657,0.0004780096,0.009911529,0.0022430045,0.00061541935,0.0048712986,0.00015703695,0.0030295309,0.018208053,0.008960061,0.9513118,0.00010955505],"about_ca_topic_score_codex":0.0011736652,"about_ca_topic_score_gemma":0.0014453812,"teacher_disagreement_score":0.002586772,"about_ca_system_score_codex":0.0006901793,"about_ca_system_score_gemma":0.0008232033,"threshold_uncertainty_score":0.009828687},"labels":[],"label_agreement":null},{"id":"W1986396848","doi":"10.1016/j.drup.2008.04.001","title":"Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents","year":2008,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Fondation de France; American Association for Cancer Research","keywords":"Medicine; Biomarker; Biomarker discovery; Trastuzumab; Imatinib; Drug; Clinical trial; Breast cancer; Druggability; Personalized medicine; Sunitinib; Oncology; Cancer; Pharmacology; Bioinformatics; Cancer research; Internal medicine; Biology; Proteomics","score_opus":0.1392766723441191,"score_gpt":0.4201719401740726,"score_spread":0.2808952678299535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986396848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013720979,0.99741673,0.0004568161,0.0011450932,0.00024743384,0.000004415627,0.000010998248,0.000010330756,0.0005708976],"genre_scores_gemma":[0.0009124487,0.99616075,0.00097611774,0.0007520724,0.00048167366,0.000009258033,0.000029898556,0.0000031915158,0.0006745807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992949,0.00015668276,0.000108034685,0.000106958156,0.00028263291,0.00005071443],"domain_scores_gemma":[0.99760604,0.0014504134,0.0001872551,0.000053052117,0.00060857314,0.00009462001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036771616,0.0009995464,0.0031073329,0.0022413405,0.00030815793,0.002197026,0.0014734833,0.0021549165,0.0026604636],"category_scores_gemma":[0.0029815147,0.00045505166,0.00075468,0.0022176367,0.0009402516,0.0037437628,0.0009906122,0.0034097265,0.0021861691],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011283127,0.000085705404,0.0002934376,0.006619154,0.000069012385,0.00025855232,0.000066768705,0.00040995193,0.0019990213,0.005090586,0.028795315,0.9561997],"study_design_scores_gemma":[0.000049937935,0.00018912437,0.0009052514,0.0024868883,0.00014804787,0.0018793012,0.00011798149,0.00041809966,0.0012207103,0.003689669,0.98886466,0.000030291949],"about_ca_topic_score_codex":0.001271373,"about_ca_topic_score_gemma":0.0027560256,"teacher_disagreement_score":0.0036771616,"about_ca_system_score_codex":0.0010401793,"about_ca_system_score_gemma":0.0016767995,"threshold_uncertainty_score":0.01944691},"labels":[],"label_agreement":null},{"id":"W1987122879","doi":"10.1016/s1368-7646(03)00024-4","title":"The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery","year":2003,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Breast Cancer Society of Canada; Cancer Research Society","keywords":"ErbB; Biology; Receptor tyrosine kinase; Receptor; Drug discovery; Signal transduction; Cancer research; Context (archaeology); Cell signaling; Bioinformatics; Cell biology; Genetics","score_opus":0.1794879031040422,"score_gpt":0.4597632419439453,"score_spread":0.2802753388399031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987122879","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000115448835,0.99828655,0.00016037535,0.00049195846,0.0002922211,0.0000029569107,0.000008563615,0.000004839647,0.00063700316],"genre_scores_gemma":[0.00056724926,0.99757034,0.0002894896,0.00040348477,0.00028781095,0.000005142615,0.000016546825,0.0000011573991,0.00085879705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997583,0.000050652037,0.000030996176,0.00004375299,0.000092560265,0.00002365351],"domain_scores_gemma":[0.99961424,0.00021324305,0.00003619941,0.000010144753,0.00009763825,0.000028477478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012147317,0.0009599724,0.001990723,0.0016662888,0.00031311065,0.0016596004,0.0010100328,0.0018579052,0.0024806692],"category_scores_gemma":[0.0008593181,0.00034440617,0.0005329395,0.0022636016,0.0008086606,0.002510792,0.00060469523,0.0025431714,0.0016803298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022574082,0.00009800812,0.00023259675,0.008433335,0.00007789677,0.0005328307,0.000105270876,0.00040089487,0.0031539518,0.0052583236,0.04970132,0.93177986],"study_design_scores_gemma":[0.000050997878,0.000119461896,0.000610081,0.0016244069,0.00009964153,0.0016090671,0.000118101096,0.00011919117,0.0005977947,0.0024066847,0.99262553,0.00001901614],"about_ca_topic_score_codex":0.001584614,"about_ca_topic_score_gemma":0.0042618476,"teacher_disagreement_score":0.0024806692,"about_ca_system_score_codex":0.0010799237,"about_ca_system_score_gemma":0.0013595904,"threshold_uncertainty_score":0.0082986355},"labels":[],"label_agreement":null},{"id":"W1993572662","doi":"10.1054/drup.2002.0235","title":"HIV drug resistance and implications for the introduction of antiretroviral therapy in resource-poor countries","year":2001,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Intensive care medicine; Drug resistance; Antiretroviral therapy; Developing country; Human immunodeficiency virus (HIV); Drug; Transmission (telecommunications); Resource (disambiguation); Immunology; Viral load; Pharmacology; Biology; Computer science","score_opus":0.00856328859968757,"score_gpt":0.2516728424776016,"score_spread":0.243109553877914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993572662","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034328967,0.05554859,0.0005275379,0.88497007,0.0039698645,0.00003775702,0.0006824536,0.0001111662,0.019823605],"genre_scores_gemma":[0.6588921,0.14915082,0.0042895493,0.16186257,0.01331243,0.00012289453,0.00068027276,0.0000585977,0.011630694],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964444,0.0022470094,0.000299685,0.00008876549,0.0006055016,0.00031470097],"domain_scores_gemma":[0.980395,0.011245998,0.0019606175,0.00028406945,0.0035352157,0.0025789978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074283727,0.00025998434,0.00043799425,0.00092418917,0.0011157761,0.0030205415,0.00090376753,0.004045408,0.011747103],"category_scores_gemma":[0.031150332,0.00025470075,0.00041873718,0.0010773799,0.0013316706,0.002786948,0.0012253555,0.002865823,0.0006523488],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007854865,0.00033060188,0.04932406,0.0019561362,0.00008018375,0.0022724643,0.0038569572,0.0012809631,0.00055617833,0.016623423,0.5131017,0.4098318],"study_design_scores_gemma":[0.00027562867,0.00084104337,0.18017063,0.004508681,0.0003400724,0.0025338123,0.021071563,0.0016485285,0.00079353014,0.01304311,0.7746039,0.0001695083],"about_ca_topic_score_codex":0.020413205,"about_ca_topic_score_gemma":0.045706984,"teacher_disagreement_score":0.020413205,"about_ca_system_score_codex":0.0016490043,"about_ca_system_score_gemma":0.00548477,"threshold_uncertainty_score":0.040588796},"labels":[],"label_agreement":null},{"id":"W2029697713","doi":"10.1016/j.drup.2008.08.005","title":"SPARC in cancer biology: Its role in cancer progression and potential for therapy","year":2008,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Matricellular protein; Cancer; Colorectal cancer; Cancer research; Biology; Tumor progression; Ovarian cancer; Cancer cell; Phenotype; Medicine; Extracellular matrix; Genetics; Gene","score_opus":0.04108337212371253,"score_gpt":0.39013273392181236,"score_spread":0.3490493617980998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029697713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018125186,0.9978818,0.0001643574,0.0005348873,0.00030999386,0.0000036867452,0.000018856947,0.0000073821416,0.00089765765],"genre_scores_gemma":[0.00075737736,0.9970794,0.00035493163,0.0004044368,0.0003311821,0.0000054263346,0.00003181521,0.000001666915,0.0010337817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983,0.00002666369,0.000024358178,0.000027147093,0.0000757803,0.000016008264],"domain_scores_gemma":[0.99962604,0.00017903726,0.000045208217,0.000011486474,0.0001050885,0.000033090524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009636281,0.0008213323,0.001643289,0.0016876784,0.00021939354,0.0010323555,0.00071121845,0.0010742341,0.0027823483],"category_scores_gemma":[0.0008154658,0.00023679301,0.00041419704,0.0021683068,0.0006267232,0.0013349227,0.0005757196,0.00180764,0.0016661611],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014396857,0.00006917997,0.00022873688,0.008141609,0.000081344406,0.00022461647,0.000033985703,0.00028832033,0.002973679,0.002318572,0.04047292,0.94502306],"study_design_scores_gemma":[0.000044452376,0.00014027016,0.00080859853,0.0015085094,0.00015714936,0.0012948982,0.000054753542,0.00012721003,0.0011111881,0.0013331263,0.9934056,0.000014250591],"about_ca_topic_score_codex":0.0011594848,"about_ca_topic_score_gemma":0.002947104,"teacher_disagreement_score":0.0027823483,"about_ca_system_score_codex":0.0006280617,"about_ca_system_score_gemma":0.001123761,"threshold_uncertainty_score":0.009307861},"labels":[],"label_agreement":null},{"id":"W2040642086","doi":"10.1016/j.drup.2012.06.001","title":"Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii","year":2012,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":262,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Acinetobacter baumannii; Multilocus sequence typing; Biology; Microbiology; Antibiotics; Molecular epidemiology; Antibiotic resistance; Carbapenem; Outbreak; Population; Multiple drug resistance; Typing; Genetics; Virology; Gene; Medicine; Bacteria; Genotype; Pseudomonas aeruginosa; Environmental health","score_opus":0.01943733421591278,"score_gpt":0.31020780493702454,"score_spread":0.2907704707211118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040642086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013003014,0.99888986,0.00010950034,0.00030967614,0.00015143187,0.0000018786693,0.000022839433,0.0000049131913,0.0003798174],"genre_scores_gemma":[0.0005552441,0.9985935,0.00020403149,0.00016967572,0.00016721632,0.0000021467008,0.000033058775,0.0000010289398,0.00027405604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997687,0.000036089037,0.000032778815,0.000048561436,0.000090992195,0.000022961582],"domain_scores_gemma":[0.99935275,0.00025531626,0.00010549038,0.000016550326,0.00021754425,0.000052368392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007487066,0.0007477083,0.0011337294,0.0016780333,0.00017667741,0.001115307,0.0007255414,0.0010118224,0.002101462],"category_scores_gemma":[0.0013436218,0.00024157276,0.00034857236,0.0018448838,0.0004213676,0.0013060115,0.00055609364,0.0011741404,0.0009938816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006900976,0.000030144853,0.00035424242,0.009637953,0.00005177926,0.00011828723,0.00003208095,0.00019354413,0.001562897,0.0012228808,0.025385082,0.96134216],"study_design_scores_gemma":[0.000016755823,0.00009540887,0.002484465,0.0036772487,0.0001883562,0.0012298976,0.00008167932,0.0001287167,0.00084371335,0.0010995112,0.9901294,0.000024824933],"about_ca_topic_score_codex":0.0020077627,"about_ca_topic_score_gemma":0.0036115528,"teacher_disagreement_score":0.002101462,"about_ca_system_score_codex":0.00071864005,"about_ca_system_score_gemma":0.0014264577,"threshold_uncertainty_score":0.00703007},"labels":[],"label_agreement":null},{"id":"W2068541511","doi":"10.1016/j.drup.2004.07.002","title":"Leishmaniasis: drugs in the clinic, resistance and new developments","year":2004,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":403,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Centers for Disease Control and Prevention","keywords":"Miltefosine; Pentamidine; Leishmaniasis; Leishmania; Medicine; Antifungal drugs; Amphotericin B; Drug resistance; Antifungal; Pharmacology; Fluconazole; Intensive care medicine; Immunology; Visceral leishmaniasis; Biology; Dermatology; Internal medicine; Microbiology; Pneumonia; Parasite hosting; Computer science","score_opus":0.060267318084281464,"score_gpt":0.36601372483918543,"score_spread":0.30574640675490394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068541511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059837497,0.9988686,0.000053353157,0.00031636772,0.00019420899,0.0000025039637,0.000008427787,0.0000059751933,0.0004907402],"genre_scores_gemma":[0.00031224656,0.9985714,0.00013324272,0.00025493038,0.00023774976,0.0000028364266,0.000013457025,9.253867e-7,0.00047318387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996475,0.00007516918,0.000057169556,0.000058158854,0.0001343056,0.000027666385],"domain_scores_gemma":[0.99915457,0.00040419877,0.0001206091,0.000026264166,0.0002205999,0.00007376492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011416385,0.0010336225,0.0024953552,0.0031807171,0.00031550907,0.0017173354,0.0010146613,0.0017025652,0.0049301405],"category_scores_gemma":[0.0012880517,0.00038715213,0.0004898081,0.0042292634,0.000682064,0.0022721642,0.00065265165,0.0020689988,0.0023723724],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017006381,0.000090516376,0.00016736944,0.015210455,0.00007003241,0.00023497763,0.000058968137,0.00024243408,0.0016515006,0.0018671142,0.043832596,0.93640393],"study_design_scores_gemma":[0.00004550366,0.00012839863,0.0006767284,0.003174607,0.00013166456,0.0012257359,0.00007353348,0.00007542229,0.00028875563,0.000841624,0.993323,0.000014928951],"about_ca_topic_score_codex":0.0018935618,"about_ca_topic_score_gemma":0.005113387,"teacher_disagreement_score":0.0049301405,"about_ca_system_score_codex":0.0009567924,"about_ca_system_score_gemma":0.0016190968,"threshold_uncertainty_score":0.016492963},"labels":[],"label_agreement":null},{"id":"W2071538535","doi":"10.1016/j.drup.2009.02.001","title":"Mutational ‘hot-spots’ in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: Sequence and structural comparison","year":2009,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Antifolate; Biology; Dihydrofolate reductase; Plasmodium falciparum; Genetics; Antimetabolite; Malaria; Gene; Immunology","score_opus":0.027419261102729693,"score_gpt":0.3193452072151339,"score_spread":0.2919259461124042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071538535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029121335,0.99558985,0.0003591169,0.00012736724,0.000056520432,0.000007511253,0.000063966625,0.0000174005,0.0008661166],"genre_scores_gemma":[0.007395769,0.9906398,0.0008619579,0.00012401999,0.000072350296,0.000005945328,0.0001753025,0.000002904488,0.0007219136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990034,0.000010953926,0.000013837424,0.000024887157,0.00003937158,0.0000105926065],"domain_scores_gemma":[0.9998547,0.000049858194,0.00004512357,0.0000045913766,0.000036940397,0.000008761629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037081607,0.0004749095,0.0011493936,0.0013252792,0.00011564476,0.00044913683,0.00068383274,0.00048101906,0.0013807609],"category_scores_gemma":[0.0003920263,0.00018313489,0.00036391642,0.0015174348,0.00023809883,0.00045736216,0.00021381272,0.00045654847,0.000619039],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020539164,0.00005242231,0.00095829717,0.008708695,0.00013325075,0.00046442955,0.000060957274,0.00051398936,0.018410273,0.0009014534,0.0066437256,0.96294713],"study_design_scores_gemma":[0.000117905205,0.00059887883,0.020794008,0.0034250976,0.0011795339,0.013615186,0.00023379296,0.0007571483,0.02146957,0.002347285,0.93537945,0.00008218858],"about_ca_topic_score_codex":0.0009466575,"about_ca_topic_score_gemma":0.0017634,"teacher_disagreement_score":0.0013807609,"about_ca_system_score_codex":0.0003162264,"about_ca_system_score_gemma":0.0004258801,"threshold_uncertainty_score":0.0046191216},"labels":[],"label_agreement":null},{"id":"W2071822666","doi":"10.1054/drup.2000.0126","title":"Biochemical mechanisms involved in overcoming HIV resistance to nucleoside inhibitors of reverse transcriptase","year":2000,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Health Canada","keywords":"Reverse transcriptase; Context (archaeology); Nucleoside; Drug resistance; Biology; Nucleoside Reverse Transcriptase Inhibitor; Enzyme; Drug; Human immunodeficiency virus (HIV); Virology; Amino acid; Genetics; Pharmacology; RNA; Biochemistry; Gene","score_opus":0.006801987319243661,"score_gpt":0.22515922886026052,"score_spread":0.21835724154101685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071822666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5889886,0.3086189,0.028591279,0.012020305,0.0014405895,0.0003663579,0.0004778696,0.0006687765,0.058827337],"genre_scores_gemma":[0.87373763,0.10306259,0.009829768,0.00083971996,0.0005151874,0.000099409146,0.00031718076,0.000032651737,0.011565938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999741,0.000072256546,0.000023002744,0.000025626541,0.00007972362,0.00005834518],"domain_scores_gemma":[0.9997843,0.000060488528,0.000065088156,0.00001623716,0.000053650205,0.000020301233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057997537,0.00057598256,0.00042605595,0.00074369257,0.00050996884,0.0015788776,0.0007101812,0.0009488577,0.0021238734],"category_scores_gemma":[0.0005476251,0.00051906734,0.00035366678,0.0003079714,0.000775833,0.0017179511,0.00039458444,0.0011662097,0.0007334251],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011441164,0.00055961736,0.0020863218,0.0017840627,0.00007157181,0.0015331059,0.0003829544,0.002643144,0.8192161,0.04449032,0.0023036823,0.123784944],"study_design_scores_gemma":[0.0001923886,0.0016010694,0.0123500675,0.0001783641,0.000179238,0.006215852,0.00059899356,0.0064051207,0.87073934,0.017486937,0.08398414,0.000068483154],"about_ca_topic_score_codex":0.0005197973,"about_ca_topic_score_gemma":0.00086755934,"teacher_disagreement_score":0.0021238734,"about_ca_system_score_codex":0.0008695928,"about_ca_system_score_gemma":0.0004724577,"threshold_uncertainty_score":0.0071050525},"labels":[],"label_agreement":null},{"id":"W2073200741","doi":"10.1016/j.drup.2012.03.003","title":"Immunotherapy: A useful strategy to help combat multidrug resistance","year":2012,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Cancer Institute; National Institute on Aging; Fondation des Etoiles; Owens Foundation","keywords":"Immunotherapy; Cytotoxic T cell; Multiple drug resistance; Immune system; Cancer immunotherapy; Cancer; Immunology; Medicine; Biology; Drug resistance; Internal medicine; Microbiology","score_opus":0.030832232956274443,"score_gpt":0.29738222501956013,"score_spread":0.26654999206328567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073200741","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009379094,0.9969715,0.0003040479,0.00085865404,0.0007884575,0.0000063124435,0.000017755594,0.000013817776,0.00094567],"genre_scores_gemma":[0.0007346148,0.9951048,0.00049160037,0.0010658137,0.0012196016,0.000011386099,0.00004872371,0.0000030318813,0.0013204082],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998099,0.000037196907,0.000022952217,0.000032647855,0.000073898584,0.00002334165],"domain_scores_gemma":[0.9996654,0.00014808612,0.000044881574,0.000011082176,0.000086808526,0.000043791668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068974594,0.0012651435,0.0015783627,0.0017518981,0.0002498354,0.0013020694,0.0007192159,0.0018163024,0.0032128019],"category_scores_gemma":[0.0007995391,0.0002873361,0.000453027,0.0012260637,0.00056323496,0.0017488078,0.0007208102,0.0038431752,0.002251105],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008185259,0.00008846822,0.00013006754,0.005608026,0.000044180633,0.00015672973,0.000021981303,0.00026230776,0.0030365386,0.0028235833,0.06590058,0.92184573],"study_design_scores_gemma":[0.000050981853,0.00012361251,0.00050129386,0.0016005065,0.000091305716,0.0009398292,0.000032231128,0.00017515932,0.00058847066,0.0021782618,0.99370193,0.00001635389],"about_ca_topic_score_codex":0.00050388573,"about_ca_topic_score_gemma":0.0015024142,"teacher_disagreement_score":0.0032128019,"about_ca_system_score_codex":0.0006048474,"about_ca_system_score_gemma":0.00090563286,"threshold_uncertainty_score":0.01074791},"labels":[],"label_agreement":null},{"id":"W2087950464","doi":"10.1016/s1368-7646(02)00021-3","title":"Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms","year":2002,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Ganciclovir; Foscarnet; Virology; Famciclovir; Herpes simplex virus; Cidofovir; Biology; Thymidine kinase; Valaciclovir; Herpesviridae; Antiviral drug; Drug resistance; Human cytomegalovirus; Nucleoside analogue; DNA polymerase; Cytomegalovirus; Virus; Polymerase; Nucleoside; Viral disease; DNA; Microbiology; Genetics","score_opus":0.03304748137064542,"score_gpt":0.3666449093710895,"score_spread":0.3335974280004441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087950464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002478167,0.99811065,0.00020237264,0.00026916902,0.00022552113,0.000004752069,0.000011269713,0.000008336451,0.0009201687],"genre_scores_gemma":[0.0010296211,0.9971456,0.00037580318,0.0002603705,0.0003544498,0.000006725986,0.000026582416,0.000001359037,0.00079937035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997725,0.000044323056,0.000038940507,0.000036016216,0.00008899141,0.000019219386],"domain_scores_gemma":[0.99940217,0.0003435959,0.0000717874,0.000015872318,0.00013505758,0.000031481664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008695749,0.00078572804,0.0017492466,0.0016432109,0.00023273697,0.0011429932,0.000887098,0.0011994153,0.0028954602],"category_scores_gemma":[0.00096593576,0.00024118565,0.0004332258,0.0017351658,0.00038820706,0.0013954365,0.00036531215,0.0013486358,0.0013831222],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014084004,0.0000694337,0.00025617576,0.005707258,0.000052327603,0.0003130824,0.000042406344,0.00017835206,0.0024094204,0.0010954819,0.014253776,0.97548145],"study_design_scores_gemma":[0.0000620635,0.00025968355,0.0016604381,0.0018767837,0.00023396286,0.003981634,0.00009197231,0.00014436609,0.0017083952,0.001160086,0.98879904,0.000021526646],"about_ca_topic_score_codex":0.0007768773,"about_ca_topic_score_gemma":0.0014820583,"teacher_disagreement_score":0.0028954602,"about_ca_system_score_codex":0.00048283616,"about_ca_system_score_gemma":0.0007475402,"threshold_uncertainty_score":0.009686351},"labels":[],"label_agreement":null},{"id":"W2092643107","doi":"10.1016/j.drup.2011.01.001","title":"Creeping baselines and adaptive resistance to antibiotics","year":2011,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Antibiotic resistance; Resistance (ecology); Adaptive response; Adaptation (eye); Biology; Antibiotics; Mechanism (biology); Drug resistance; Intensive care medicine; Evolutionary biology; Biotechnology; Genetics; Medicine; Ecology; Neuroscience","score_opus":0.025393598519693174,"score_gpt":0.2899207888008317,"score_spread":0.2645271902811385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092643107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008039686,0.9980526,0.00020517195,0.00058612355,0.0004357148,0.000002478018,0.000010842392,0.00000826873,0.0006183529],"genre_scores_gemma":[0.00053752406,0.9974782,0.00024103714,0.0004255981,0.0005986826,0.0000042007728,0.000020653022,0.000002230705,0.0006919443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970204,0.00005321309,0.000037924434,0.000054881733,0.000121733974,0.000030229477],"domain_scores_gemma":[0.9993635,0.00032039883,0.00008084096,0.000022085562,0.0001626506,0.000050505394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092486176,0.0010668539,0.0017914198,0.0017477542,0.00034151084,0.0016419025,0.001179783,0.002295909,0.0028289198],"category_scores_gemma":[0.0016933824,0.00042779595,0.00038104499,0.0019348209,0.0012593577,0.0025242008,0.00091632025,0.0028633876,0.0019568102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000920272,0.00005230651,0.00017277033,0.0077319047,0.000040384082,0.00019054844,0.000057558456,0.00037488824,0.002193766,0.0072600245,0.060104437,0.9217293],"study_design_scores_gemma":[0.000013950919,0.000039668557,0.0003930985,0.0014092214,0.000047316586,0.0008526803,0.000051356325,0.000108577115,0.00043154098,0.0034867541,0.9931504,0.000015504771],"about_ca_topic_score_codex":0.0012005549,"about_ca_topic_score_gemma":0.0022817652,"teacher_disagreement_score":0.0028289198,"about_ca_system_score_codex":0.001027453,"about_ca_system_score_gemma":0.001081655,"threshold_uncertainty_score":0.0094637275},"labels":[],"label_agreement":null},{"id":"W2114168745","doi":"10.1016/j.drup.2015.08.001","title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","year":2015,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":330,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Sanofi Pasteur; Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma; Bundesministerium für Bildung und Forschung; Cidara Therapeutics; National Institute of Allergy and Infectious Diseases; Medical Research Council; Celgene; Pfizer; Dainippon Sumitomo Pharma; Janssen Pharmaceuticals; Gilead Sciences; Radboud Universiteit; Sanofi; European Commission; Viropharma; Bristol-Myers Squibb","keywords":"Azole; Voriconazole; Micafungin; Aspergillosis; Aspergillus fumigatus; Itraconazole; Echinocandin; Medicine; Intensive care medicine; Drug resistance; Aspergillus; Amphotericin B; Esophageal candidiasis; Microbiology; Biology; Antifungal; Immunology; Fluconazole; Dermatology","score_opus":0.02548187277548414,"score_gpt":0.29582742481636504,"score_spread":0.2703455520408809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114168745","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013710179,0.4171676,0.0039245347,0.33143154,0.16340218,0.0003452273,0.0010435586,0.00026172123,0.081052706],"genre_scores_gemma":[0.025315471,0.5409498,0.009554314,0.1912163,0.1755976,0.00062421884,0.0033359367,0.00014590565,0.053260397],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758124,0.0008098764,0.0003899835,0.00019412913,0.00079769996,0.00022702814],"domain_scores_gemma":[0.9914654,0.0018892505,0.00092408597,0.00011520045,0.0048363353,0.00076974044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033751125,0.000736796,0.0010461292,0.0013981903,0.0005339205,0.0018966862,0.0017496054,0.005394685,0.012860043],"category_scores_gemma":[0.011981961,0.0002990413,0.0011985205,0.00089412654,0.0006150546,0.001530342,0.0008375476,0.0040743034,0.0077284193],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005313105,0.000029581757,0.00021487196,0.0019330384,0.00002768553,0.0005085478,0.000067671484,0.000113818955,0.00033679476,0.0008628077,0.8195072,0.17634487],"study_design_scores_gemma":[0.000025095831,0.00002324046,0.00039980124,0.0030870405,0.000043613076,0.00094734755,0.00004846759,0.00010374313,0.00010966751,0.0008182051,0.9943825,0.000011183494],"about_ca_topic_score_codex":0.0019055514,"about_ca_topic_score_gemma":0.0027122071,"teacher_disagreement_score":0.012860043,"about_ca_system_score_codex":0.0015455163,"about_ca_system_score_gemma":0.0021168948,"threshold_uncertainty_score":0.043021083},"labels":[],"label_agreement":null},{"id":"W2123781894","doi":"10.1016/j.drup.2007.01.003","title":"Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapy","year":2007,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":452,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Canadian Institutes of Health Research; CancerCare Manitoba Foundation; Manitoba Medical Service Foundation; Manitoba Health Research Council","keywords":"Cell cycle; Programmed cell death; Context (archaeology); Cell biology; Cyclin-dependent kinase; Biology; Cell growth; Apoptosis; Cancer research; Protein kinase B; Regulator; PI3K/AKT/mTOR pathway; Signal transduction; Genetics; Gene","score_opus":0.05591776088849937,"score_gpt":0.3349819565211766,"score_spread":0.27906419563267726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123781894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013510461,0.99603003,0.00035035616,0.001447654,0.00063427666,0.0000049721048,0.00001367451,0.000013775071,0.0013701565],"genre_scores_gemma":[0.00061704783,0.99601495,0.00075056445,0.00084613264,0.000587277,0.000010994906,0.000027676062,0.0000021138521,0.0011431777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980086,0.000039146562,0.00002401756,0.00003364939,0.00008027283,0.000021902591],"domain_scores_gemma":[0.9996364,0.00017126706,0.000036609257,0.000009519016,0.000115127994,0.000031043277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089013134,0.001013415,0.0018853551,0.0011807908,0.00037562978,0.001524186,0.0011137605,0.001616486,0.0032657618],"category_scores_gemma":[0.00064580096,0.00032833876,0.0004836676,0.0018257301,0.00076427637,0.002190221,0.0006986714,0.0035626495,0.0020867407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013577114,0.000112004964,0.00020330337,0.008010476,0.00008404031,0.00029749304,0.00006623732,0.0005412424,0.0045141145,0.009844949,0.07541326,0.90077704],"study_design_scores_gemma":[0.000040155453,0.000084751526,0.00052188215,0.0012418737,0.00008978237,0.00082997157,0.00007951963,0.00017492428,0.0005298332,0.0041778376,0.9922123,0.000017296705],"about_ca_topic_score_codex":0.00079621794,"about_ca_topic_score_gemma":0.0026200288,"teacher_disagreement_score":0.0032657618,"about_ca_system_score_codex":0.0008761249,"about_ca_system_score_gemma":0.0010725964,"threshold_uncertainty_score":0.010925055},"labels":[],"label_agreement":null},{"id":"W2156149052","doi":"10.1016/j.drup.2006.08.001","title":"Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: Towards personalized medicine","year":2006,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"Canadian Space Agency; CancerCare Manitoba Foundation; Muscular Dystrophy Association; Manitoba Health Research Council; Manitoba Medical Service Foundation; Health Sciences Centre Foundation; Parent Project Muscular Dystrophy","keywords":"Personalized medicine; Cancer; Computational biology; Bioinformatics; Biology; Medicine; Genetics","score_opus":0.080257720066636,"score_gpt":0.45804743444390794,"score_spread":0.37778971437727193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156149052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008465041,0.99701595,0.00093976624,0.001051126,0.0003977642,0.000006845873,0.00001773787,0.000011506303,0.00047452736],"genre_scores_gemma":[0.00085950596,0.99498004,0.0019901476,0.0007498883,0.0007608497,0.000013513238,0.000041247906,0.0000024835253,0.0006023608],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989543,0.00030291465,0.00013480423,0.0001407991,0.0004267101,0.000040500432],"domain_scores_gemma":[0.99660814,0.0022470378,0.00025615338,0.000108340995,0.000670329,0.00011009143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038637326,0.001295111,0.0037886326,0.0036070102,0.00028385685,0.0018938162,0.001636875,0.0021505663,0.0024337627],"category_scores_gemma":[0.0031722123,0.00052232784,0.0009072713,0.0029699972,0.0012503964,0.0026802947,0.0008545382,0.0035997818,0.0017991062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093160066,0.00009646348,0.00063942646,0.006584754,0.00016225975,0.00017098506,0.000046179946,0.00037785538,0.0016446381,0.0046802033,0.01854704,0.9669571],"study_design_scores_gemma":[0.00006725302,0.00018668198,0.0025305375,0.0035223616,0.00028628734,0.0017934352,0.000114296665,0.00043560658,0.0015266772,0.009153225,0.98032767,0.000055870212],"about_ca_topic_score_codex":0.0014271499,"about_ca_topic_score_gemma":0.002099754,"teacher_disagreement_score":0.0038637326,"about_ca_system_score_codex":0.0012063467,"about_ca_system_score_gemma":0.0017596605,"threshold_uncertainty_score":0.020433664},"labels":[],"label_agreement":null},{"id":"W2171452890","doi":"10.1054/drup.2000.0152","title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment","year":2000,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":519,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pseudomonas aeruginosa; Antibiotics; Efflux; Antibiotic resistance; Microbiology; Periplasmic space; Biology; Resistance (ecology); Bacterial outer membrane; Bacteria; Genetics; Gene; Ecology; Escherichia coli","score_opus":0.00525736061795576,"score_gpt":0.24360459976691584,"score_spread":0.23834723914896008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171452890","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010480622,0.9191602,0.0020215178,0.056069955,0.0036611517,0.000027668762,0.00011119016,0.00012722303,0.008340415],"genre_scores_gemma":[0.05035857,0.9220011,0.003632995,0.010051935,0.00804531,0.00003483006,0.00016899007,0.000037162892,0.005669032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896395,0.0003136511,0.00013410719,0.00008722512,0.00040512587,0.00009597417],"domain_scores_gemma":[0.99560755,0.0019077216,0.00043196778,0.00014731027,0.0015257995,0.00037961453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035510005,0.0005051767,0.0009472932,0.0011256792,0.00029792666,0.0022278703,0.0006494781,0.0019875728,0.0033134932],"category_scores_gemma":[0.0046490026,0.00022918484,0.0004756797,0.00095821964,0.00067975576,0.002618463,0.0005794032,0.0022066329,0.0008413747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006987793,0.00031574295,0.0029918458,0.0024768752,0.000058477697,0.00027058512,0.00020017316,0.00037185985,0.008001912,0.00469892,0.044441476,0.9354733],"study_design_scores_gemma":[0.00012955185,0.0016178247,0.016609006,0.0020342502,0.00024358365,0.0019629977,0.00044098007,0.00080548093,0.0053097294,0.004518048,0.9662662,0.00006231303],"about_ca_topic_score_codex":0.0010482696,"about_ca_topic_score_gemma":0.0022997973,"teacher_disagreement_score":0.0035510005,"about_ca_system_score_codex":0.0010447492,"about_ca_system_score_gemma":0.0012724021,"threshold_uncertainty_score":0.018779755},"labels":[],"label_agreement":null},{"id":"W2273626774","doi":"10.1016/j.drup.2016.02.001","title":"Could drugs inhibiting the mevalonate pathway also target cancer stem cells?","year":2016,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Mevalonate pathway; Cancer; Cancer stem cell; Cancer research; Carcinogenesis; Cancer cell; Metastasis; Hippo signaling pathway; Biology; Signal transduction; Epithelial–mesenchymal transition; Stem cell; Cell biology; Bioinformatics; Reductase; Genetics; Biochemistry; Enzyme","score_opus":0.013004977418209964,"score_gpt":0.2755649961688785,"score_spread":0.26256001875066853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2273626774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017769921,0.996792,0.00022037947,0.0010622037,0.0005322211,0.000005068735,0.000031168136,0.000016503793,0.001162673],"genre_scores_gemma":[0.001317072,0.99577564,0.00027565705,0.00073945423,0.00039235773,0.000007705951,0.000061582294,0.000002911602,0.0014275733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989235,0.00001777151,0.000013170957,0.000018049428,0.00004224743,0.000016555125],"domain_scores_gemma":[0.9998448,0.000064560794,0.000022940545,0.0000061071933,0.00004315882,0.00001842785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004337859,0.00057967915,0.0011196694,0.000890418,0.00018633304,0.00086601946,0.0006830912,0.00095407467,0.004445365],"category_scores_gemma":[0.0005277183,0.00017367856,0.00045096528,0.00074251846,0.00036795312,0.0011283283,0.00050436164,0.0019051732,0.0020118025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018315898,0.00006263869,0.00019155066,0.0073288083,0.0000913753,0.00026145717,0.000032938806,0.0002487764,0.0041163596,0.0052310964,0.058330376,0.92392135],"study_design_scores_gemma":[0.00004236171,0.000097756434,0.00033814856,0.0010048987,0.00010228054,0.00076215353,0.000028565482,0.00008701945,0.000859008,0.0017575017,0.9949078,0.000012495864],"about_ca_topic_score_codex":0.0006971081,"about_ca_topic_score_gemma":0.0024069292,"teacher_disagreement_score":0.004445365,"about_ca_system_score_codex":0.00050336483,"about_ca_system_score_gemma":0.0006452934,"threshold_uncertainty_score":0.01487124},"labels":[],"label_agreement":null},{"id":"W2767031674","doi":"10.1016/j.drup.2017.10.003","title":"Not only P-glycoprotein: Amplification of the ABCB1- containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins","year":2017,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministry of Health, British Columbia; Sapienza Università di Roma; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Multiple drug resistance; Biology; Efflux; P-glycoprotein; Cancer cell; Cancer research; Drug resistance; ATP-binding cassette transporter; Epigenetics; Locus (genetics); Vinca; Gene; Cancer; Genetics; Pharmacology; Transporter","score_opus":0.034160511131234444,"score_gpt":0.31473638836263707,"score_spread":0.28057587723140265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767031674","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602315,0.015769681,0.008964671,0.0021883275,0.00021705325,0.000076165976,0.001664825,0.00055891316,0.010328792],"genre_scores_gemma":[0.979131,0.0077653956,0.0018108507,0.00030065933,0.0000923425,0.00007282711,0.0018853694,0.00008010111,0.008861512],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968374,0.0000374594,0.000021280917,0.000092747396,0.00013225454,0.000032469616],"domain_scores_gemma":[0.9998073,0.000028945155,0.000050065617,0.000029530263,0.00004701633,0.000037254034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001413089,0.00037682123,0.0003789134,0.00058461144,0.00025359483,0.0006414745,0.00017426047,0.00051476224,0.003974085],"category_scores_gemma":[0.00031148532,0.00019601642,0.00025502418,0.000569445,0.00027435107,0.0004136456,0.00040280592,0.00068250875,0.0019091461],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005812112,0.000023486818,0.0020808128,0.000058319612,0.000022151784,0.00057344313,0.000030231096,0.000057939156,0.98745257,0.00025901824,0.0005663264,0.008817584],"study_design_scores_gemma":[0.000051574396,0.00064871495,0.10495332,0.000026570182,0.00020347068,0.01726383,0.000120903554,0.0014128528,0.8091654,0.0010609941,0.06504806,0.000044339526],"about_ca_topic_score_codex":0.00040431722,"about_ca_topic_score_gemma":0.0004903348,"teacher_disagreement_score":0.003974085,"about_ca_system_score_codex":0.00029460553,"about_ca_system_score_gemma":0.00022741492,"threshold_uncertainty_score":0.013294637},"labels":[],"label_agreement":null},{"id":"W2794341756","doi":"10.1016/j.drup.2018.01.004","title":"Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018","year":2018,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Hepatitis C virus research","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"NS5A; Hepatitis C virus; NS5B; NS3; Medicine; Virology; Drug resistance; Hepacivirus; Virus; Drug development; Drug; Pharmacology; Biology; Genetics","score_opus":0.05785593860325694,"score_gpt":0.38527833261309774,"score_spread":0.3274223940098408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794341756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015274204,0.99771035,0.00007700631,0.0006683757,0.00058435113,0.000009897726,0.00011334015,0.000012786153,0.0006711315],"genre_scores_gemma":[0.0011518917,0.9959376,0.00035191135,0.0012441938,0.00063028676,0.000009747643,0.00017502297,0.0000033745375,0.0004959715],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995413,0.00009444657,0.00012893962,0.00005435862,0.00013875573,0.0000421526],"domain_scores_gemma":[0.99809283,0.00089474977,0.00040700065,0.000038370217,0.0004674267,0.0000995336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011175456,0.00074064045,0.0016978242,0.0026913865,0.0002012387,0.0016070098,0.00083282037,0.0012684024,0.006334886],"category_scores_gemma":[0.0033077518,0.0002852929,0.001032749,0.002208228,0.00033393907,0.0015396351,0.0008428796,0.001700121,0.0013619869],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020306944,0.000058547947,0.0005196592,0.03949198,0.0002863547,0.00019133947,0.00006802539,0.0001477842,0.0008575931,0.0009803773,0.0791953,0.878],"study_design_scores_gemma":[0.00010164101,0.00013150428,0.0018017167,0.016813567,0.001204049,0.0012558072,0.00009964563,0.00012232299,0.00034529314,0.00078985415,0.97730446,0.000030195713],"about_ca_topic_score_codex":0.0012896612,"about_ca_topic_score_gemma":0.0039269007,"teacher_disagreement_score":0.006334886,"about_ca_system_score_codex":0.00066896435,"about_ca_system_score_gemma":0.0023427142,"threshold_uncertainty_score":0.021192253},"labels":[],"label_agreement":null},{"id":"W2800029404","doi":"10.1016/j.drup.2018.04.001","title":"Corrigendum to “Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018” [Drug Resist. Updates 37 (March) (2018) 17–39]","year":2018,"lang":"en","type":"erratum","venue":"Drug Resistance Updates","topic":"Hepatitis C virus research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Drug; Virology; Drug resistance; Medicine; Relevance (law); Hepatitis C virus; Virus; Biology; Pharmacology; Genetics; Political science","score_opus":0.03217018304041553,"score_gpt":0.32048403887188537,"score_spread":0.28831385583146985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800029404","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006836414,0.002408915,0.00020340996,0.08403751,0.900337,0.000049825274,0.0010355186,0.0003368692,0.011522679],"genre_scores_gemma":[0.0033392974,0.0150359245,0.0015787841,0.20632344,0.415844,0.00021719886,0.0037773503,0.00053642574,0.35334754],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962022,0.0005226973,0.00063090894,0.00037284486,0.0018297115,0.00044160942],"domain_scores_gemma":[0.97721046,0.004851814,0.0017677906,0.0007628124,0.013922596,0.0014845395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024315314,0.001932831,0.0023461964,0.003532521,0.0024736254,0.0038491786,0.002587076,0.008518272,0.13523166],"category_scores_gemma":[0.032846984,0.001078715,0.0021741746,0.0022965511,0.001696118,0.0023348716,0.0020588778,0.007904285,0.11809684],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000104460105,0.0000062393046,0.000025317599,0.000051641247,0.000002600148,0.00006418729,0.0000033913586,0.000009886567,0.000011392322,0.00010324976,0.99592316,0.0037884559],"study_design_scores_gemma":[0.000040835952,0.000029405348,0.0006442196,0.00037366743,0.0000242775,0.00020578549,0.00003278927,0.00009288951,0.00012115528,0.00053545245,0.99787736,0.000022082011],"about_ca_topic_score_codex":0.015402944,"about_ca_topic_score_gemma":0.029783675,"teacher_disagreement_score":0.13523166,"about_ca_system_score_codex":0.003324156,"about_ca_system_score_gemma":0.0056429706,"threshold_uncertainty_score":0.45239496},"labels":[],"label_agreement":null},{"id":"W2920869071","doi":"10.1016/j.drup.2018.03.003","title":"Glioblastoma cancer stem cell biology: Potential theranostic targets","year":2019,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; Children's Hospital Research Institute of Manitoba; Southlake Regional Health Center; CancerCare Manitoba","funders":"HORIZON EUROPE Marie Sklodowska-Curie Actions; Royan Institute","keywords":"Glioblastoma; Stem cell; Cancer stem cell; Biology; Cancer research; Stem cell biology; Brain cancer; Cancer; Computational biology; Medicine; Cell biology; Genetics; Gene","score_opus":0.022101269485741776,"score_gpt":0.31505085595418414,"score_spread":0.2929495864684424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920869071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009169563,0.9974222,0.00013316974,0.00066978915,0.00042487954,0.0000046370255,0.000031266554,0.000011549236,0.0012107982],"genre_scores_gemma":[0.00060147996,0.9970932,0.00019787019,0.00066381326,0.00041015263,0.0000067284873,0.000052638003,0.0000019130396,0.0009721783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983966,0.000027668062,0.00001763795,0.00002487867,0.00006337977,0.000026695981],"domain_scores_gemma":[0.9996846,0.0001357903,0.000039622137,0.000007977368,0.000089375826,0.000042710184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061721687,0.0008231453,0.0012677672,0.0015254144,0.00020413092,0.001227097,0.0006295989,0.0011053476,0.0051369783],"category_scores_gemma":[0.0007499537,0.00024452966,0.00041185715,0.0014330612,0.00042947635,0.0012230375,0.00075875357,0.0022366277,0.0023206251],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009045624,0.000057152796,0.000099944664,0.008711831,0.000047961064,0.0000989935,0.000027765598,0.0002814141,0.001685547,0.0033941462,0.07069662,0.91480815],"study_design_scores_gemma":[0.000030344481,0.000096292024,0.0003190471,0.002041376,0.000085607324,0.00035898056,0.00003168985,0.00012279779,0.00036073115,0.0016942986,0.99484646,0.00001253662],"about_ca_topic_score_codex":0.00092610816,"about_ca_topic_score_gemma":0.003480481,"teacher_disagreement_score":0.0051369783,"about_ca_system_score_codex":0.000683762,"about_ca_system_score_gemma":0.001041645,"threshold_uncertainty_score":0.017184854},"labels":[],"label_agreement":null},{"id":"W3042832159","doi":"10.1016/j.drup.2020.100719","title":"FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy","year":2020,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Lopinavir; Hydroxychloroquine; Favipiravir; Ritonavir; Azithromycin; Clinical trial; Chloroquine; Pharmacology; Intensive care medicine; Virology; Immunology; Disease; Antibiotics; Coronavirus disease 2019 (COVID-19); Malaria; Virus; Internal medicine; Viral load; Biology","score_opus":0.12587865412803,"score_gpt":0.48196220077526863,"score_spread":0.3560835466472386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042832159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003289312,0.99482167,0.00019402962,0.0008042588,0.0003258424,0.000045839075,0.00022242466,0.000027449923,0.0032294597],"genre_scores_gemma":[0.001992213,0.99462295,0.00052520866,0.0012324707,0.000170322,0.000037279326,0.0002607899,0.000005051038,0.0011538354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996879,0.000072576186,0.00005474656,0.000040036408,0.00010098833,0.000043848147],"domain_scores_gemma":[0.9990741,0.0004463631,0.00018229405,0.000020336827,0.00021754787,0.000059228067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015833126,0.0008702277,0.0018808802,0.002000822,0.00023595305,0.0013963864,0.0009101007,0.0012767275,0.012326395],"category_scores_gemma":[0.0020203835,0.00030576432,0.0014083701,0.0017087148,0.00040342868,0.00106249,0.0006953441,0.0022392718,0.0027420227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039756257,0.000114352224,0.0001642854,0.025781682,0.0002614485,0.00012018047,0.000036696554,0.0002627916,0.0015513735,0.0022266472,0.044872433,0.92421055],"study_design_scores_gemma":[0.0004774956,0.00058111345,0.0010633497,0.015549527,0.0011270707,0.0005056564,0.00005621797,0.0001624896,0.0006438953,0.0011407387,0.9786654,0.000027016697],"about_ca_topic_score_codex":0.0017324275,"about_ca_topic_score_gemma":0.0056263474,"teacher_disagreement_score":0.012326395,"about_ca_system_score_codex":0.0009635602,"about_ca_system_score_gemma":0.0023585798,"threshold_uncertainty_score":0.041235864},"labels":[],"label_agreement":null},{"id":"W4200113990","doi":"10.1016/j.drup.2021.100794","title":"An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment","year":2021,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":292,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Research Institute in Oncology and Hematology","funders":"Silesian University of Technology","keywords":"Medicine; Hydroxychloroquine; Pandemic; Lopinavir; Coronavirus disease 2019 (COVID-19); Ribavirin; Intensive care medicine; Ritonavir; Interim analysis; Clinical endpoint; Randomized controlled trial; Interim; Disease; Internal medicine; Viral load; Virology; Virus; Infectious disease (medical specialty)","score_opus":0.11328396671619102,"score_gpt":0.4875776992917716,"score_spread":0.3742937325755806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200113990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010816808,0.9975448,0.000091115595,0.0006418053,0.00043468174,0.000019235064,0.00012910269,0.000016531007,0.0010145295],"genre_scores_gemma":[0.00064589654,0.99708074,0.0002919032,0.0010781762,0.00029090195,0.000019136789,0.00014578752,0.0000029013584,0.00044456703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995459,0.000114479524,0.00012015923,0.00004305434,0.0001292274,0.000047133493],"domain_scores_gemma":[0.998621,0.0007093749,0.00027914243,0.000027176759,0.00028004608,0.000083362334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017238894,0.0009781115,0.0022624515,0.0031715112,0.00021935628,0.0015853037,0.0008319538,0.0014277542,0.00804248],"category_scores_gemma":[0.002845225,0.0003942126,0.001515595,0.0024237528,0.00036737794,0.0015717093,0.0009197083,0.0022146832,0.0018292895],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002947075,0.00007992246,0.00015216864,0.04719429,0.0003206572,0.00013567499,0.000045964425,0.00026817704,0.001115731,0.0014016319,0.08114784,0.8678433],"study_design_scores_gemma":[0.00026852908,0.00036998818,0.0009072638,0.024178691,0.0015343133,0.0005204885,0.000045105302,0.00015192294,0.00038683403,0.000944127,0.9706644,0.000028273542],"about_ca_topic_score_codex":0.0014942182,"about_ca_topic_score_gemma":0.0044021565,"teacher_disagreement_score":0.00804248,"about_ca_system_score_codex":0.000904311,"about_ca_system_score_gemma":0.0026104976,"threshold_uncertainty_score":0.026904762},"labels":[],"label_agreement":null},{"id":"W4211153257","doi":"10.1016/j.drup.2003.10.002","title":"DNA methylation and cancer therapy","year":2003,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"DNA methylation; CpG site; Methylation; Biology; DNA methyltransferase; Epigenomics; RNA-Directed DNA Methylation; Methyltransferase; DNA; Illumina Methylation Assay; Epigenetics of physical exercise; Epigenetics; Cancer epigenetics; Cancer research; Genetics; Molecular biology; Gene; Gene expression","score_opus":0.026668337005175558,"score_gpt":0.3297473750495071,"score_spread":0.3030790380443315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211153257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009344531,0.9947555,0.00042075384,0.0013271008,0.0013869645,0.000007733413,0.00001267029,0.00001700119,0.001978763],"genre_scores_gemma":[0.0013041652,0.99008065,0.00064794143,0.0014120996,0.0018379124,0.000017464296,0.000038456445,0.000004987549,0.0046564015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997031,0.00007178348,0.000025052494,0.000048405214,0.00012115536,0.00003041075],"domain_scores_gemma":[0.99972504,0.000120356264,0.000027475475,0.000015656817,0.000077380166,0.00003403216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010381963,0.0011036316,0.0019446226,0.0017294242,0.00048196156,0.0013101153,0.0013766217,0.0020098342,0.0052482784],"category_scores_gemma":[0.00095292093,0.00040116368,0.00046194522,0.0016288053,0.0010891344,0.0015362727,0.00093043223,0.0039484063,0.0029368545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013834456,0.000096369105,0.00014892098,0.0031846513,0.00006521032,0.00033764195,0.000056760415,0.0005686976,0.002966641,0.006621697,0.11555622,0.87025887],"study_design_scores_gemma":[0.0000276623,0.000045168774,0.00022382256,0.00044114172,0.000036281253,0.0007367565,0.000026190266,0.00013199287,0.0004899173,0.0024859027,0.995346,0.000009124764],"about_ca_topic_score_codex":0.0015085557,"about_ca_topic_score_gemma":0.0047878274,"teacher_disagreement_score":0.0052482784,"about_ca_system_score_codex":0.0011657136,"about_ca_system_score_gemma":0.0010327076,"threshold_uncertainty_score":0.017557263},"labels":[],"label_agreement":null},{"id":"W4387731505","doi":"10.1016/j.drup.2023.101012","title":"Antibiotic failure: Beyond antimicrobial resistance","year":2023,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Perelman School of Medicine, University of Pennsylvania; Defense Threat Reduction Agency; Killam Trusts; Brain and Behavior Research Foundation; National Institute of General Medical Sciences; United Therapeutics Corporation; International Association for Dental Research; University of British Columbia; University of Pennsylvania; National Institutes of Health; ACE Foundation; Procter and Gamble","keywords":"Antibiotic resistance; Antibiotics; Intensive care medicine; Medicine; Sepsis; Antimicrobial; Microbiome; Biology; Microbiology; Immunology; Bioinformatics","score_opus":0.014720306058480846,"score_gpt":0.2833561460175726,"score_spread":0.26863583995909174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387731505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026064921,0.9978624,0.00012479728,0.00076578313,0.00069027767,0.000001963475,0.000009837976,0.000009170421,0.0005096239],"genre_scores_gemma":[0.00031080737,0.9963671,0.00019452184,0.0011507273,0.0013578234,0.0000044838625,0.000027609594,0.0000032615785,0.0005835928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995241,0.00012248139,0.00005757172,0.0000693871,0.00018183311,0.00004470881],"domain_scores_gemma":[0.9987577,0.00067318964,0.00012976261,0.000033209075,0.0002711367,0.00013502393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011668602,0.0013159567,0.0025420901,0.0018892777,0.00028068907,0.0017734135,0.0011469595,0.0021887035,0.004903125],"category_scores_gemma":[0.0022790213,0.00025323316,0.0006550908,0.0016629092,0.00086916244,0.0018505686,0.0010601559,0.004106201,0.00269094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009438113,0.000046040917,0.0001317854,0.00922975,0.00007451295,0.00017283607,0.000029705678,0.00028088517,0.0006023827,0.0040889,0.1128411,0.87240773],"study_design_scores_gemma":[0.000035778703,0.000079545476,0.00043321666,0.005035022,0.0001056886,0.0008252066,0.000045357934,0.00014804356,0.00013298346,0.0028885365,0.99025327,0.000017269174],"about_ca_topic_score_codex":0.0010788327,"about_ca_topic_score_gemma":0.002657771,"teacher_disagreement_score":0.004903125,"about_ca_system_score_codex":0.0009470048,"about_ca_system_score_gemma":0.001516547,"threshold_uncertainty_score":0.016402602},"labels":[],"label_agreement":null},{"id":"W4407599227","doi":"10.1016/j.drup.2025.101213","title":"Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"H2020 Marie Skłodowska-Curie Actions; FP7 People: Marie-Curie Actions; National Institutes of Health; Universidad de Zaragoza; National Institute of Allergy and Infectious Diseases; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; European Commission; Horizon 2020 Framework Programme","keywords":"Antibiotics; Medicine; Lactam; Tuberculosis; Microbiology; Chemistry; Biology; Pathology","score_opus":0.0657759882485501,"score_gpt":0.4339001372049818,"score_spread":0.36812414895643164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407599227","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75479645,0.21354946,0.00809202,0.0009820522,0.00068811915,0.000444331,0.0010830901,0.00044493587,0.019919414],"genre_scores_gemma":[0.9171098,0.06642874,0.006888859,0.00062259636,0.0002770834,0.000112630216,0.0010197461,0.000027277083,0.0075133373],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999224,0.000012356102,0.0000065571335,0.000014662882,0.00003208577,0.000011990297],"domain_scores_gemma":[0.9999558,0.0000078904495,0.000015330808,0.0000033739843,0.0000075675607,0.0000101266505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009669449,0.00029679944,0.00032495311,0.0003175751,0.0001790908,0.00024661512,0.00024607373,0.00031053557,0.0018200531],"category_scores_gemma":[0.00013971853,0.00009426447,0.00024932998,0.00019429317,0.00019470543,0.00018785564,0.00023342343,0.0004941139,0.0005187451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009548524,0.00047540158,0.0015457341,0.0010676669,0.000040967836,0.000848194,0.0000542523,0.00026136692,0.82800746,0.00045109366,0.00164729,0.16464572],"study_design_scores_gemma":[0.0005032494,0.010986057,0.012580024,0.00025213815,0.00021105641,0.0073842867,0.000097891694,0.001278353,0.82953024,0.0002662843,0.13685913,0.000051251405],"about_ca_topic_score_codex":0.00029092262,"about_ca_topic_score_gemma":0.0006605309,"teacher_disagreement_score":0.0018200531,"about_ca_system_score_codex":0.00013875184,"about_ca_system_score_gemma":0.00020791362,"threshold_uncertainty_score":0.006088674},"labels":[],"label_agreement":null},{"id":"W4410266122","doi":"10.1016/j.drup.2025.101251","title":"MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; University Health Network","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero della Salute; Fondazione AIRC per la ricerca sul cancro ETS","keywords":"PTEN; Downregulation and upregulation; Head and neck squamous-cell carcinoma; Cancer research; microRNA; PI3K/AKT/mTOR pathway; Head and neck; Mechanism (biology); Medicine; Head and neck cancer; Basal cell; Oncology; Internal medicine; Biology; Cancer; Signal transduction; Gene; Genetics; Surgery","score_opus":0.005825822523603009,"score_gpt":0.23790518535370522,"score_spread":0.23207936283010222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410266122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969015,0.011719882,0.0060249893,0.0010377216,0.00019114153,0.00007745918,0.00036242383,0.00036548724,0.0112058595],"genre_scores_gemma":[0.99287146,0.0032744699,0.0010874239,0.00015342119,0.00003512568,0.000020529993,0.00018379895,0.00001585659,0.0023580005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998497,0.00001587184,0.0000116996125,0.000021777896,0.000072564195,0.000028386074],"domain_scores_gemma":[0.99994516,0.000010189142,0.000018053617,0.000007927279,0.000010795822,0.000007890855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024713154,0.0002806318,0.0002106116,0.0002826985,0.00017519445,0.0007236345,0.0002971732,0.00036456,0.0012778887],"category_scores_gemma":[0.00020978547,0.00015559375,0.00033014486,0.00019513567,0.00026660113,0.00028391072,0.00021601634,0.00043375266,0.00027803704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019512673,0.00008290916,0.0045500263,0.00014173423,0.000048139707,0.0027803436,0.00005765295,0.00026775122,0.9658554,0.0025252106,0.0009594999,0.02253614],"study_design_scores_gemma":[0.00008173744,0.0007042315,0.06851966,0.000030180392,0.00025108375,0.015199923,0.00017585584,0.0053398977,0.8793469,0.0010293893,0.029289141,0.000031994925],"about_ca_topic_score_codex":0.00036184746,"about_ca_topic_score_gemma":0.0006535638,"teacher_disagreement_score":0.0012778887,"about_ca_system_score_codex":0.00044250442,"about_ca_system_score_gemma":0.0003053364,"threshold_uncertainty_score":0.0042749643},"labels":[],"label_agreement":null},{"id":"W4413147816","doi":"10.1016/j.drup.2025.101291","title":"Defining homologous recombination deficiency status in pancreatic ductal adenocarcinoma: Clinical implications for evaluating response to platinum chemotherapy","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"Science and Technology Planning Project of Guangdong Province; Guangzhou Science and Technology Program key projects; National Natural Science Foundation of China","keywords":"Pancreatic ductal adenocarcinoma; Homologous recombination; Chemotherapy; Medicine; Oncology; Adenocarcinoma; Internal medicine; Pancreatic cancer; Biology; Genetics; Cancer; Gene","score_opus":0.03174208239471961,"score_gpt":0.40307234455219065,"score_spread":0.37133026215747106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413147816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841404,0.0009016877,0.00022044523,0.000024917725,0.0000033358756,0.0000056171193,0.00008850098,0.0000032998048,0.00033819338],"genre_scores_gemma":[0.9995547,0.00015858028,0.0001626738,0.000009776758,0.0000049208193,0.000002750192,0.00006828438,8.792087e-7,0.00003756868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950755,0.00015946572,0.000107584056,0.000085624415,0.00009439764,0.000045359226],"domain_scores_gemma":[0.99851614,0.00052736903,0.0005488922,0.000088358545,0.00015024305,0.00016902319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093717134,0.00017705314,0.00032659358,0.000984966,0.0001635729,0.00055437844,0.00020245308,0.00023552959,0.00046647596],"category_scores_gemma":[0.0022397244,0.000090585316,0.00019824506,0.0007988273,0.0002598213,0.00025313586,0.00036174813,0.00023208371,0.00013381473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001110722,0.000008080331,0.99663866,0.0000071831428,0.000013468368,0.000063860636,0.000017964256,0.000035966958,0.0006816382,0.0000050483077,0.000012853519,0.002404165],"study_design_scores_gemma":[0.0000035875971,0.00012840374,0.9974826,0.000008488583,0.00003510346,0.001126289,0.000126811,0.0003547201,0.0004929596,0.000029634679,0.00020876518,0.0000026443597],"about_ca_topic_score_codex":0.00035671212,"about_ca_topic_score_gemma":0.00045169584,"teacher_disagreement_score":0.000984966,"about_ca_system_score_codex":0.00013331344,"about_ca_system_score_gemma":0.00012666539,"threshold_uncertainty_score":0.004956305},"labels":[],"label_agreement":null},{"id":"W4415641574","doi":"10.1016/j.drup.2025.101319","title":"ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China; Foundation for Innovative Research Groups of the National Natural Science Foundation of China; Foundation for Innovative Research Groups of Hubei Province of China; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Breast Cancer Research Foundation","keywords":"Synthetic lethality; Poly ADP ribose polymerase; PARP inhibitor; Ovarian cancer; DNA damage; DNA repair; Olaparib; Programmed cell death","score_opus":0.011116964085680128,"score_gpt":0.30246942756489226,"score_spread":0.2913524634792121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415641574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95811105,0.014678185,0.007700524,0.0023247462,0.0003946473,0.00011563043,0.002191537,0.0008451103,0.013638628],"genre_scores_gemma":[0.9817479,0.0067334813,0.0019551187,0.0002703987,0.000025701043,0.000040155704,0.0020667291,0.000057360594,0.0071031386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997603,0.000032952714,0.000019015342,0.000033505465,0.00008137982,0.00007272508],"domain_scores_gemma":[0.9998871,0.000019864532,0.000029035637,0.00001751336,0.000018751374,0.000027718974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032902125,0.000391939,0.00038097074,0.00041726604,0.00023699472,0.00062947685,0.00047372628,0.00042057398,0.0036370785],"category_scores_gemma":[0.00026529402,0.00028352253,0.0002963445,0.00030940582,0.00035977334,0.00027888847,0.00035881822,0.0015191126,0.000905802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079524267,0.00024023376,0.0011070452,0.00016697799,0.000071019196,0.00014438605,0.000034891575,0.0007790569,0.9686257,0.0010694981,0.0023326373,0.024633314],"study_design_scores_gemma":[0.000121668374,0.0009785545,0.007900079,0.000017879905,0.00005074186,0.0006666501,0.000092848626,0.0014436445,0.9637162,0.00016959662,0.024825,0.000017045348],"about_ca_topic_score_codex":0.0014622959,"about_ca_topic_score_gemma":0.0034225318,"teacher_disagreement_score":0.0036370785,"about_ca_system_score_codex":0.00057843287,"about_ca_system_score_gemma":0.00048120983,"threshold_uncertainty_score":0.012167215},"labels":[],"label_agreement":null},{"id":"W7117586634","doi":"10.1016/j.drup.2025.101349","title":"AMPKα2 attenuates doxorubicin induced ferroptosis by promoting NCOA4 degradation in triple negative breast cancer","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Medical and Health Research Project of Zhejiang Province; Natural Science Foundation of Ningbo; Higher Education Discipline Innovation Project; Natural Science Foundation of Zhejiang Province; National Natural Science Foundation of China","keywords":"Triple-negative breast cancer; Doxorubicin; Degradation (telecommunications); Breast cancer; Cancer; Apoptosis","score_opus":0.010150329936666574,"score_gpt":0.2806916703124635,"score_spread":0.2705413403757969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117586634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8588189,0.11730693,0.0038501278,0.0068975626,0.0017865902,0.000076843615,0.00094279303,0.00045341544,0.009866775],"genre_scores_gemma":[0.950584,0.033332083,0.0023519874,0.0010249811,0.00037553048,0.000053312953,0.000949498,0.00004443259,0.011284114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994135,0.000011256034,0.000005379992,0.000009127706,0.00001708674,0.0000158131],"domain_scores_gemma":[0.9999434,0.0000084156245,0.000015285581,0.0000056424556,0.000014833375,0.00001257709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001753604,0.00019615571,0.00026249848,0.00015748732,0.000127653,0.00030118666,0.00018282275,0.00021676364,0.0027458575],"category_scores_gemma":[0.00016605083,0.000097221586,0.00017089707,0.00010182297,0.00012118937,0.00017554309,0.00013859951,0.0006881403,0.00043156155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005983502,0.00062245794,0.0033361726,0.0010285553,0.00022864688,0.00029062244,0.00008505553,0.00036967619,0.80946296,0.00093474705,0.015120133,0.16253749],"study_design_scores_gemma":[0.0014251505,0.0051512537,0.04381285,0.00026110213,0.0006594768,0.0022536528,0.0003571233,0.0027498908,0.7175416,0.0011895264,0.22454351,0.000054897777],"about_ca_topic_score_codex":0.0004351427,"about_ca_topic_score_gemma":0.0015269781,"teacher_disagreement_score":0.0027458575,"about_ca_system_score_codex":0.00025760772,"about_ca_system_score_gemma":0.00021933996,"threshold_uncertainty_score":0.009185851},"labels":[],"label_agreement":null}]}